Chadi Hage Chehade

9PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersImage processingCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Jun 16, 2025
Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay

|Jan 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.

Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh

|Dec 18, 2024
Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary Malignancies.

Zeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal

|Sep 14, 2024
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma.

Emre Dal, Ayana Srivastava, Beverly Chigarira

|Aug 08, 2024
Targeting the FGFR Pathway in Patients with Advanced Solid Tumors.

Chadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal

Pageof 2